The Brazilian aerospace firm posted $94.0 million in adjusted EBIT for Q1, up from $88.2 million a year earlier. Embraer reported first-quarter revenue of $1.44 billion, exceeding expectations by $20 million. Adjusted EBIT reached $94.0 million, reflecting a 6.5% margin, c
The biotech firm reported increased cash burn in Q1 2026, with operating activities consuming $3.2 million. Revelation Biosciences reported a first-quarter GAAP loss of $2.71 per share, reflecting ongoing operational costs. The company’s net cash used for operating activit
ANI Pharmaceuticals reports stronger-than-expected Q1 earnings and revenue, driven by a 24.1% year-over-year increase in adjusted EBITDA. ANI Pharmaceuticals posted first-quarter non-GAAP earnings per share of $2.05, exceeding estimates by $0.75, as revenue rose 20.5% year
The drugmaker attributes modest revenue growth to new product launches and a 3% list price increase for BAQSIMI. Amphastar Pharmaceuticals expects BAQSIMI revenue to remain flat or rise by low single digits in Q1 2026. The company cited recent product launches and a 3% lis
The software firm’s cloud revenue share exceeds 50% for the first time, driving its fiscal 2026 outlook. JFrog projected FY 2026 revenue between $628M and $632M, reflecting strong demand for its cloud-based DevOps platform. The company cited execution discipline and a stra
The geospatial intelligence firm cites $160 million in contract awards and over 50% subscription growth from new satellite capabilities. BlackSky expects 2026 revenue between $130 million and $150 million, driven by its third-generation satellite technology. The company re
The healthcare data firm reported Q1 2026 revenue of $55.9 million and adjusted EBITDA margin of 27%, exceeding guidance. Definitive Healthcare Corp. (DH) forecasted full-year 2026 revenue between $220 million and $226 million, while guiding Q2 EBITDA margin to 24%-26%. Th
AdvanSix Q1 revenue beats by $39.28M AdvanSix reported a Q1 Non-GAAP EPS of -$0.50, missing by $0.03. The company's revenue was $404.18M, a 7.0% year-over-year increase, beating by $39.28M. AdvanSix expects Capital Expenditures of $75 to $95 million in 2026, down
Fidus Investment (FDUS) declares $0.43/share quarterly dividend, in line with previous. - Forward yield 9.32% - Board of Directors declared a Supplemental Dividend of $0.19/share payable: - Payable June 29; for shareholders of record June 16; ex-div June 16. - See FDUS Dividend...</stron
The miner posted $2.52 adjusted EPS for Q1 2026, exceeding forecasts, while free cash flow jumped 190% year-on-year to $1.2bn. AngloGold Ashanti reported first-quarter adjusted earnings per share of $2.52, beating expectations by $0.28. Revenue reached $3.15bn, up 63.2% fr
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.